TJP1 protein may identify multiple myeloma patients most likely to benefit from proteasome inhibitors
A gene known as TJP1 (tight junction protein 1) could help determine which multiple myeloma patients would best benefit from proteasome inhibitors such as bortezomib, as well as combination approaches to enhance proteasome inhibitor sensitivity, according to a study led by The University of Texas MD Anderson Cancer Center.
Multiple myeloma is a cancer that forms from white blood cells found in the bone marrow, normally vital to...
Breast cancer survivors share hope and help with new book
More than 40 breast cancer survivors – many treated at The University of Texas MD Anderson Cancer Center in The Woodlands – have published...
MD Anderson and Helsinn Healthcare SA enter strategic alliance to improve life of patients conducting clinical studies in cancer supportive and palliative care
The University of Texas MD Anderson Cancer Center and Helsinn, a Swiss pharmaceutical group focused on building quality cancer care, today...
Teen cancer patients and their families get ‘red carpet’ ready for a special prom
The University of Texas MD Anderson Children’s Cancer Hospital, in collaboration with local restaurants and businesses, will host a special prom for its pediatric cancer patients on Saturday, April 30 from 5 p.m. to 9 p.m.
The Great Gatsby-themed prom takes place at MD Anderson Cancer Center, and is expected to welcome more than 100 teen patients and their families. The “Prom Party Palooza” includes three separate parties for patients...
Cancer, meet your match: Andrew Sabin Family Fellows announced
Eight of The University of Texas MD Anderson Cancer Center’s top young researchers today were formally named Andrew Sabin Family Fellows at...
Monitoring sugar metabolism in liver may be a key to cancer diagnosis
Scientists may have discovered a significant new diagnostic marker for liver cancer, according to a paper published in the April 18 online...
First computer program developed to detect DNA mutations in single cancer cells
Researchers at The University of Texas MD Anderson Cancer Center have announced a new method for detecting DNA mutations in a single cancer...
Study drug LOXO-101 shows tumor regression in varied cancers
A phase I study of the drug LOXO-101 appears to significantly reduce tumors in patients with varied types of genetically defined cancer, according...
First-ever nivolumab study to treat aggressive anal cancer appears promising
A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results...
MD Anderson researcher named AACR’s Margaret Foti Award recipient
Waun Ki Hong, M.D., professor of Thoracic Head & Neck Medical Oncology at The University of Texas MD Anderson Cancer Center, has been...
MD Anderson’s Keeling Center Open House Set for April 22
The University of Texas MD Anderson Cancer Center’s Michale E. Keeling Center for Comparative Medicine and Research will open its doors to...
Saks Fifth Avenue to host event benefiting MD Anderson
The University of Texas MD Anderson Cancer Center and Saks Fifth Avenue will join forces April 27 at a cocktail and store preview event to...
People with hepatitis C are two to five times more likely to develop certain head and neck cancers
Long associated with liver cancer and non-Hodgkin’s lymphoma, a study from The University of Texas MD Anderson Cancer Center reveals for the...
Study suggests link between obesity and kidney cancer
Receptors for leptin, a protein hormone, may be associated with tumor recurrence in patients with renal cell carcinoma (RCC), providing further...
MD Anderson experts join new Parker Institute for Cancer Immunotherapy
Cancer immunotherapy leaders at The University of Texas MD Anderson Cancer Center will work with experts at five other cancer centers in a...
Zayed Building opens doors to state-of-the-art personalized cancer research
The University of Texas MD Anderson Cancer Center welcomed His Highness Sheikh Hamed Bin Zayed Al Nahyan, Chairman of the Crown Prince Court...
2 MD Anderson experts named to National Cancer Moonshot advisory panel
Two cancer experts at The University of Texas MD Anderson Cancer Center have been named to a blue ribbon panel to advise the National Cancer...